Solesence, Inc. balance sheet SLSN

As of Jun 30, 2026, Solesence, Inc. had total assets of $46.4 million. Total assets were down 22.5% from a year earlier. Stockholders' equity was $13.2 million. It held $1.0 million in cash and investments against $8.4 million of total debt, net debt of $7.4 million. The current ratio, current assets divided by current liabilities, was 0.97.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Assets
Cash
1
-74.5%
1
-8.6%
1
-18.2%
2
-21.2%
2
+232.7%
1
-31.3%
1
-19.8%
1
-11.2%
1
-31.2%
2
+9.9%
2
+39.5%
Cash and investments
1
-74.5%
1
-8.6%
1
-18.2%
2
-21.2%
2
+232.7%
1
-31.3%
1
-19.8%
1
-11.2%
1
-31.2%
2
+9.9%
2
+39.5%
Receivables
9
-15.4%
7
+40.4%
5
+40.4%
3
-26.8%
5
+20.2%
4
+34.3%
3
+202.3%
1
+17.0%
1
-25.7%
1
+156.9%
0
-14.4%
Inventory
13
-34.7%
19
-8.7%
20
+102.0%
10
+13.5%
9
+45.0%
6
+40.4%
4
+69.9%
3
+13.9%
2
+61.9%
1
+79.4%
1
+16.6%
Total current assets
25
-34.8%
29
-1.9%
29
+80.0%
16
-1.9%
17
+43.3%
12
+31.3%
9
+77.2%
5
+6.3%
5
+1.4%
5
+34.9%
3
+27.4%
Property and equipment, net
15
+9.1%
14
+12.5%
13
+46.9%
9
+9.0%
8
+68.7%
5
+64.3%
3
+27.2%
2
+20.9%
2
+14.8%
2
+16.4%
1
-25.0%
Total assets
46
-22.5%
50
+0.1%
50
+52.1%
33
-2.0%
34
+18.2%
28
+109.7%
14
+44.5%
9
+42.7%
7
+4.8%
6
+29.4%
5
+5.9%
Liabilities and equity
Accounts payable
5
-27.9%
4
-54.9%
9
+45.3%
6
-1.6%
6
+78.4%
4
+67.7%
2
+21.6%
2
+8.7%
2
+54.9%
1
+55.2%
1
+31.7%
Total current liabilities
26
+15.4%
14
-46.0%
26
+65.3%
16
+12.7%
14
+88.5%
7
+8.2%
7
+53.9%
4
+21.2%
4
+79.7%
2
+56.1%
1
+47.7%
Stockholders' equity
13
-8.8%
18
+18.0%
15
+685.8%
2
-66.3%
6
-24.3%
7
+173.2%
3
+80.8%
2
+9.2%
1
-57.2%
3
+15.8%
3
-2.4%
Debt
Debt due within a year
—
—
—
—
—
—
0
+0.0%
0
—
—
—
Long-term debt
—
—
—
—
1
+5.0%
—
1
—
—
—
—
Lease liabilities
8
-13.4%
9
-12.1%
10
-1.5%
10
+5.2%
10
-20.8%
12
+423.4%
2
-18.3%
3
—
—
—
Total debt
8
-13.4%
9
-12.1%
10
-1.5%
10
-4.4%
11
-21.9%
12
+423.4%
4
+12.4%
3
—
—
—
Net cash
-7
-31.4%
-8
+12.6%
-9
-1.8%
-9
+0.2%
-9
+34.5%
-12
-731.7%
-3
-29.9%
-2
—
—
—
Ratios
Current ratio
0.97x
2.07x
1.14x
1.05x
1.20x
1.58x
1.30x
1.13x
1.29x
2.28x
2.64x
Debt to equity
0.64x
0.51x
0.69x
5.49x
1.92x
1.66x
1.40x
2.25x
—
—
—
Debt to EBITDA
—
3.67x
1.70x
—
—
4.12x
2.07x
—
—
—
—
Return on equity
-22.10%
10.15%
28.34%
-230.81%
-46.43%
31.08%
36.20%
-198.94%
-150.36%
-24.41%
-45.97%
Return on assets
-6.26%
3.58%
8.47%
-13.35%
-7.82%
8.17%
7.30%
-32.07%
-31.68%
-12.59%
-26.50%
Book value per share
0.19
0.25
0.21
0.04
0.11
0.15
0.07
0.04
0.04
0.10
0.09
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Listed as
SLSN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Romeoville, IL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
883107
Former names
NANOPHASE TECHNOLOGIES Corp (until Mar 31, 2025); NANOPHASE TECHNOLOGIES CORPORATION (until Feb 1, 2016)

Other Perfumes, Cosmetics & Other Toilet Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.